glp 1 anesthesia ASA Advises No Longer Holding GLP-1 Agents Prior to Surgery for Most Patients GLP-1 drugs and aspiration risk

[CrossRef] [PubMed] [Google Scholar] Carnitines as mitochondrial modulators of oocyte and embryo bioenergetics

Retatrutide simultaneously activates GLP-1, GIP, and glucagon receptors, creating synergistic effects that enhance insulin secretion, suppress appetite, slow gastric emptying, and increase energy expenditure

The cagrilintide + tirzepatide stack is a two-compound research protocol that combines an FDA-approved obesity drug with an investigational fullness peptide

Animal Model:Neonatal Sprague-Dawley rats (male, 18-22g, postnatal day 7), hypoxic-ischemic brain damage (HIBD) model [2] Dosage:100 mg/kg Administration:Intraperitoneal injection, once daily, for 14 consecutive days starting 24 hours after HIBD induction Result:Brain injury: Reduced infarct volume by 40% compared to the HIBD control group as measured by triphenyltetrazolium chloride (TTC) staining